News

2018 News Releases

Keyword Search
 
2018 | 2017 | 2016
DateTitle 
05/08/18Aralez Announces First Quarter 2018 Financial Results
-1Q 2018 Net Revenues Increased to $38.1 Million Versus $26.0 Million in 1Q 2017- MISSISSAUGA, Ontario, May 8, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced financial results for the first quarter ending March 31, 2018. The Company also highlighted certain recent corporate and commercial updates. All figures are in U.S. dollars. Recent Corporate & Commercial Updates Earlier today, the Company announced th... 
Printer Friendly Version
05/08/18Aralez Announces New Strategic Direction
-Focus on Canadian Operations, supported by Toprol-XL® Franchise Revenues and Vimovo® Royalties- -Discontinuation of U.S. Commercial Operations, with Significant Reductions in Operating Expenses- -Actively Exploring Strategic Alternatives for Business- MISSISSAUGA, Ontario, May 8, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced that, based on its continuing exploration and evaluation of numerous opportunities to ... 
Printer Friendly Version
04/27/18Aralez To Announce First Quarter 2018 Results On May 8, 2018
-Executive Management to Host Conference Call on May 8, 2018 at 8:00 a.m. ET- MISSISSAUGA, Ontario, April 27, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) today announced that it will report its first quarter 2018 financial results on Tuesday, May 8, 2018, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:00 a.m. ET on such date to discuss the financial results and r... 
Printer Friendly Version
03/13/18Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results
-4Q 2017 Net Revenues Increased to $28.0 Million Versus $20.0 Million in the 4Q 2016- -Full-Year Net Revenues Increased to $105.9 Million Versus $54.3 Million in Full-Year 2016- -Provides 2018 Full-Year Financial Guidance- MISSISSAUGA, Ontario, March 13, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced financial results for the fourth quarter and year ended December 31, 2017. The Company also highlighted cert... 
Printer Friendly Version
03/06/18Aralez To Announce Fourth Quarter And Full-Year 2017 Results On March 13, 2018
-Executive Management to Host Conference Call on March 13, 2018 at 8:30 a.m. ET- MISSISSAUGA, Ontario, March 6, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) today announced that it will report its 2017 fourth quarter and full-year financial results on Tuesday, March 13, 2018, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET on such date to discuss the fin... 
Printer Friendly Version
01/30/18Aralez to Present at the 2018 BIO CEO and Investor Conference
MISSISSAUGA, Ontario, Jan. 30, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty pharmaceutical company, today announced the executive management will participate in the 2018 BIO CEO and Investor Conference to be held February 12-13, 2018 in New York. Adrian Adams, Chief Executive Officer, will provide an overview of the Company at 11:00 a.m. local time on Tuesday, February 13, 2018. A live webcast and audio archive for the event may be accessed fr... 
Printer Friendly Version
Data provided by Nasdaq. Minimum 15 minutes delayed.